Drilldown: Medicines
Appearance
Medicines > fda max:
Formulation-dependent
& onset
:
Postprandial glucose effect within days; HbA1c by 12 weeks
or
Symptom improvement within weeks 
& onset
:
Postprandial glucose effect within days; HbA1c by 12 weeks
or
Symptom improvement within weeks 
Use the filters below to narrow your results.
There are no results for this report.

